DIVERSITY IN ECONOMIC EVALUATIONS HAMPERS VALID DECISION-MAKING IN METASTATIC COLORECTAL CANCER

Author(s)

Merkens GL¹, Tamminga HJ¹, Hovels A², Frederix GW¹
¹Utrecht University, Utrecht, The Netherlands, ²Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands

Presentation Documents

PRM105--strong-u-merkens-gl-u-sup-1-sup-strong-tamminga-hj-sup-1-sup-hovels-a-sup-2-sup-frederix-gw-sup-1-sup-br-sup-1-sup-utrecht-university-utrecht-the-netherlands-sup-2-sup-utrecht-institute-for-pharmaceutical-sciences-utrecht-the-nether ...

OBJECTIVES: Especially within expensive disease areas it is essential to look further down the road and compare outcomes not only within economic evaluations but also between. The objective of this research is to identify whether it is possible to compare outcomes of metastatic colorectal cancer evaluations by identifying all outcomes, structural differences, similarities and their validation status. METHODS:

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PRM105

Topic

Methodological & Statistical Research

Topic Subcategory

Modeling and simulation

Disease

Oncology

Explore Related HEOR by Topic

Methodology

Presentation